Opaleye Management Inc. - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 53 filers reported holding CIDARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$148,000
-94.6%
73,351
-92.4%
0.02%
-95.4%
Q3 2020$2,766,000
-22.8%
970,6640.0%0.54%
-25.2%
Q2 2020$3,582,000
+59.4%
970,664
+7.1%
0.72%
+21.5%
Q1 2020$2,247,000
-15.2%
906,056
-9.4%
0.60%
-18.9%
Q1 2019$2,650,000
-6.0%
1,000,000
-16.7%
0.73%
-30.2%
Q4 2018$2,820,000
-46.6%
1,200,0000.0%1.05%
-21.7%
Q3 2018$5,280,000
-15.4%
1,200,0000.0%1.34%
-16.8%
Q2 2018$6,240,000
+553.4%
1,200,000
+879.6%
1.62%
+240.0%
Q1 2017$955,000
+115.6%
122,500
+184.9%
0.48%
+60.5%
Q2 2016$443,00043,0000.30%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders